TransMedics to Participate in the 44th Annual J.P. Morgan Healthcare Conference

TransMedics (Nasdaq: TMDX) said members of its management team will present at the 44th Annual J.P.

Rhea-AI Summary

TransMedics (Nasdaq: TMDX) said members of its management team will present at the 44th Annual J.P. Morgan Healthcare Conference on Monday, January 12, 2026 at 3:00 pm PST / 6:00 pm EST. The presentation will be available live and as an archived webcast on the company’s Investors website. The company also noted its standard investor presentation is available at the same link.

Argus Dec 31 session

-0.22% close to close Open Argus

Details

News Market Reaction – TMDX

On Dec 31, the first trading day after this news, TMDX closed 0.22% below the previous close.

Data tracked by StockTitan Argus for the Dec 31 session.

Market Context

This announcement highlights TransMedics’ planned participation in the 44th J.P. Morgan Healthcare C...

Analysis

This announcement highlights TransMedics’ planned participation in the 44th J.P. Morgan Healthcare Conference on January 12, 2026 at 3:00 pm PST. These forums often provide updates on strategy and financial outlook but, by themselves, do not alter fundamentals. Historically, earnings and operational disclosures have driven more meaningful price responses than calendar events. Investors may focus on any new metrics, guidance changes, or program updates discussed during the webcast and archived presentation.

Key Figures

Conference edition: 44th Annual Conference date: January 12, 2026 Presentation time PST: 3:00 pm PST +1 more

Conference edition

44th Annual

J.P. Morgan Healthcare Conference

Conference date

January 12, 2026

Scheduled presentation date

Presentation time PST

3:00 pm PST

J.P. Morgan Healthcare Conference slot

Presentation time EST

6:00 pm EST

J.P. Morgan Healthcare Conference slot

Historical Context

5 past events · Latest: Dec 24

5 events

1. Dec 24

   Inducement grants

   24h Move

   -2.2%

   New employee inducement option and RSU grants under Nasdaq Rule 5635(c)(4).

2. Dec 09

   Operational collaboration

   24h Move

   -1.3%

   Strategic collaboration to deploy organ transport hubs and support infrastructure.

3. Nov 18

   Conference participation

   24h Move

   +3.2%

   Management participation in Piper Sandler healthcare conference fireside chat.

4. Oct 31

   Inducement grants

   24h Move

   -5.2%

   Inducement equity awards with new options and RSUs for 15 employees.

5. Oct 29

   Quarterly earnings

   24h Move

   +3.5%

   Q3 2025 revenue and earnings growth with raised full‑year guidance.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

ANDOVER, Mass., Dec. 30, 2025 /PRNewswire/ -- TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart, and liver failure, today announced that members of the management team will present at the upcoming 44^th Annual J.P. Morgan Healthcare Conference. The presentation will take place on Monday, January 12, 2026, at 3:00 pm Pacific Standard Time / 6:00 pm Eastern Standard Time.

Event: 44^th Annual J.P. Morgan Healthcare Conference 
Date: Monday, January 12, 2026
Time: 3:00 pm PST

A live and archived webcast of the presentations will be available on the "Investors" section of the TransMedics website at https://investors.transmedics.com/. The Company's standard investor presentation is also available through this link.

About TransMedics Group, Inc.
TransMedics is the world's leader in portable extracorporeal warm perfusion and assessment of donor organs for transplantation. Headquartered in Andover, Massachusetts, the company was founded to address the unmet need for more and better organs for transplantation and has developed technologies to preserve organ quality, assess organ viability prior to transplant, and potentially increase the utilization of donor organs for the treatment of end-stage heart, lung, and liver failure.

Investor Contact:
Brian Johnston
Laine Morgan
332-895-3222
Investors@transmedics.com 

View original content to download multimedia:https://www.prnewswire.com/news-releases/transmedics-to-participate-in-the-44th-annual-jp-morgan-healthcare-conference-302650761.html

SOURCE TransMedics Group, Inc.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

When will TransMedics (TMDX) present at the 44th Annual J.P. Morgan Healthcare Conference?

TransMedics will present on Monday, January 12, 2026 at 3:00 pm PST / 6:00 pm EST.

How can investors watch the TransMedics (TMDX) presentation from J.P. Morgan on January 12, 2026?

Investors can view the live webcast and archived presentation on the TransMedics Investors website at investors.transmedics.com.

Will TransMedics (TMDX) make the J.P. Morgan presentation available after the event?

Yes; a recorded, archived webcast will be accessible on the company’s Investors website after the live presentation.

What topics will TransMedics (TMDX) cover at the J.P. Morgan Healthcare Conference presentation?

The company said management will present its standard investor presentation, covering recent developments and corporate outlook.

Where can I find the TransMedics (TMDX) investor presentation referenced for the January 12, 2026 event?

The standard investor presentation is available for download on the TransMedics Investors webpage at investors.transmedics.com.

Does TransMedics (TMDX) require registration to watch the J.P. Morgan presentation webcast?

The company indicated the webcast will be available on its Investors site; check the investors.transmedics.com page for any registration details.